Literature DB >> 21402546

Reduced Tim-3 expression on human T-lymphotropic virus type I (HTLV-I) Tax-specific cytotoxic T lymphocytes in HTLV-I infection.

Nashwa H Abdelbary1, Hazem M Abdullah, Toshio Matsuzaki, Daisuke Hayashi, Yuetsu Tanaka, Hiroshi Takashima, Shuji Izumo, Ryuji Kubota.   

Abstract

T cell immunoglobulin and mucin domain-containing molecule-3 (Tim-3) and programmed cell death-1 (PD-1) are T cell exhaustion molecules. We investigated the expression of Tim-3 and PD-1 in human T-lymphotropic virus type I (HTLV-I) infection. Tim-3 expression, but not PD-1 expression, was reduced on CD4(+) and CD8(+) T cells of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients and HTLV-I carriers as compared with healthy controls. Tim-3 expression was also reduced in HTLV-I Tax-specific cytotoxic T lymphocytes (CTLs) as compared with cytomegalovirus-specific CTLs. Tim-3(+), but not PD-1(+), Tax-specific CTLs produced less interferon-γ and exhibited low cytolytic activity. However, we observed no difference in the expression of Tim-3 or cytolytic activity between Tax-specific CTLs of HAM/TSP patients or carriers. Moreover, HTLV-I-infected CD4(+) T cells showed decreased Tim-3 expression. These data suggest that Tim-3 expression is reduced in HTLV-I infection and that a high number of Tim-3(-) HTLV-I-specific CTLs preserves their cytolytic activity, thereby controlling viral replication.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21402546     DOI: 10.1093/infdis/jiq153

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis.

Authors:  Andrew J Steelman; Roger Smith; C Jane Welsh; Jianrong Li
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

2.  Lack of recall response to Tax in ATL and HAM/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1.

Authors:  Sharrón L Manuel; Mohit Sehgal; John Connolly; George Makedonas; Zafar K Khan; Jay Gardner; Michael R Betts; Pooja Jain
Journal:  J Clin Immunol       Date:  2013-07-26       Impact factor: 8.317

3.  HTLV-1 Infection and Neuropathogenesis in the Context of Rag1-/-γc-/- (RAG1-Hu) and BLT Mice.

Authors:  Rashida Ginwala; Breanna Caruso; Zafar K Khan; Ajinkya Pattekar; Glen M Chew; Michael J Corley; Ronak Loonawat; Steven Jacobson; Sreesha Sreedhar; Lishomwa C Ndhlovu; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2017-04-04       Impact factor: 4.147

4.  Role of IL-21 in HTLV-1 infections with emphasis on HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Taraneh Rajaei; Hamid Farajifard; Houshang Rafatpanah; Reza Bustani; Narges Valizadeh; Bahareh Rajaei; Seyed Abdolrahim Rezaee
Journal:  Med Microbiol Immunol       Date:  2017-04-04       Impact factor: 3.402

5.  Tim-3 directly enhances CD8 T cell responses to acute Listeria monocytogenes infection.

Authors:  Jacob V Gorman; Gabriel Starbeck-Miller; Nhat-Long L Pham; Geri L Traver; Paul B Rothman; John T Harty; John D Colgan
Journal:  J Immunol       Date:  2014-02-24       Impact factor: 5.422

6.  An altered maturation and adhesion phenotype of dendritic cells in diseased individuals compared to asymptomatic carriers of human T cell leukemia virus type 1.

Authors:  Sharrón L Manuel; Mohit Sehgal; Zafar K Khan; James J Goedert; Michael R Betts; Pooja Jain
Journal:  AIDS Res Hum Retroviruses       Date:  2013-07-19       Impact factor: 2.205

7.  Minocycline modulates antigen-specific CTL activity through inactivation of mononuclear phagocytes in patients with HTLV-I associated neurologic disease.

Authors:  Yoshimi Enose-Akahata; Eiji Matsuura; Yuetsu Tanaka; Unsong Oh; Steven Jacobson
Journal:  Retrovirology       Date:  2012-02-15       Impact factor: 4.602

8.  Conference highlights of the 15th International Conference on Human Retrovirology: HTLV and related retroviruses, 4-8 June 2011, Leuven, Gembloux, Belgium.

Authors:  Fabiola Martin; Charles R M Bangham; Vincenzo Ciminale; Michael D Lairmore; Edward L Murphy; William M Switzer; Renaud Mahieux
Journal:  Retrovirology       Date:  2011-10-28       Impact factor: 4.602

9.  The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases.

Authors:  Mari Kannagi; Atsuhiko Hasegawa; Ayako Takamori; Shuichi Kinpara; Atae Utsunomiya
Journal:  Front Microbiol       Date:  2012-09-03       Impact factor: 5.640

10.  Human T-lymphotropic Virus Type I (HTLV-I) Proviral Load and Clinical Features in Iranian HAM/TSP Patients: Comparison of HTLV-I Proviral Load in HAM/TSP Patients.

Authors:  Rosita Vakili; Faezeh Sabet; Sanaz Aahmadi; Reza Boostani; Houshang Rafatpanah; Ali Shamsian; S A Rahim Rezaee
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.